JCM, Vol. 13, Pages 2058: Depression in Rheumatoid Arthritis: Prevalence and Effects on Disease Activity

JCM, Vol. 13, Pages 2058: Depression in Rheumatoid Arthritis: Prevalence and Effects on Disease Activity

Journal of Clinical Medicine doi: 10.3390/jcm13072058

Authors: Cătălina-Elena Ionescu Claudiu Costinel Popescu Mihaela Agache Georgiana Dinache Cătălin Codreanu

Background:The primary objective of this study was to estimate depression’s prevalence in a cohort of rheumatoid arthritis (RA) patients, and the secondary objective was to evaluate the impact of depression on disease activity over time. Methods: We included all patients with RA presenting to our clinic from 2019 to 2020, who had three follow-up visits available. Depression prevalence was calculated using the patient’s history of diagnosed depression, and disease activity was assessed using the disease activity score for 28 joints (DAS28) and its components: tender joint count (TJC), swollen joint count (SJC), pain value on a visual analog scale (VAS), and inflammatory markers. Results: A total of 400 RA patients were included, 75 of whom had diagnosed depression, generating a prevalence of 18.8%. The mean values of DAS28 and its components were higher, with statistical significance, in the depression subgroup at all three follow-ups (p < 0.001). Conclusions: Depression is prevalent in the RA population, and leads to higher disease activity in dynamic evaluations. Assessing depression could be a psychological marker for RA prognosis with an important outcome in controlling disease activity.